全球尿动力学检测市场 – 行业趋势及 2029 年预测

市场分析和规模

根据欧洲泌尿外科协会 2013 年发布的一份报告，全球泌尿外科感染流行率 (GPIU) 研究数据显示，泌尿外科住院患者中约有 10% 患有医疗相关感染。由于失去膀胱控制而导致尿失禁被称为尿失禁。尿失禁影响着全球约 5 亿人，是推动全球尿动力学检测市场发展的关键因素之一。

Data Bridge Market Research 分析，尿动力学检测市场规模在 2021 年为 3.3734 亿美元，到 2029 年将飙升至 6.4313 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 8.4%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Urodynamic testing may determine how well the bladder works. The test aids in determining the causes of urine leakage, obstruction in the bladder, or the urine's flow channel. Numerous conditions can cause urinary symptoms include frequent urination, urgency when urinating, painful urination, recurrent urinary tract infections, poor urine flow, and incontinence. The precise cause of the problem can be identified with the aid of an urodynamic test.

Urodynamic Testing Market Dynamics

Drivers

• Increasing prevalence of diseases

Over the forecast period of 2022 to 2029, the prevalence of disorders such bladder cancer, benign prostatic hypertrophy, neurogenic bladder dysfunction, and overactive bladder will likely continue to rise, which will likely drive the urodynamic testing market. Additionally, it is anticipated that the increased prevalence of urinary system issues brought on by pregnancy, injuries, ageing, and other factors that necessitate urine testing to start treatment will advance the market growth for urodynamic testing.

• Increasing in urological disorders

The increase in urological disorders and the quick expansion of healthcare programmes to raise awareness of urological issues are both factors in the expansion of the target market. The incidence of bladder infections, rising rates of target diseases, rising disposable income globally, and an ageing population are all factors driving up demand for urodynamic testing.

• Raise awareness of urological issues

The target market is expanding due to increased efforts being made to raise awareness of urological issues and the accessibility of urological disorder therapy and diagnostics. Additionally, during the aforementioned forecast period, the market for urodynamic testing will benefit from numerous growth opportunities due to ongoing product approvals, an expanding network of testing facilities, and the simple availability of medical reimbursement for urological preliminary tests.

Opportunities

• Increase in the number of research and development activities 

The market growth is fuelled by an expanding network of testing facilities, and the simple availability of medical reimbursement for urological preliminary tests. This will provide beneficial opportunities for the market growth.

Restraints/Challenges

The high costs associated with development of new drug entity and distribution, will slow the market's growth rate. The market will be hampered by a lack of awareness about this testing. The presence of substitutes will pose a challenge to market growth during the forecast period.

This urodynamic testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urodynamic testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Urodynamic Testing Market

The COVID-19 epidemic has slightly influenced healthcare systems and the market. The COVID-19 pandemic's effects on urology practise in the United States and insights into the changes in health care delivery that have been noticed in this multimodal medical specialty. While the number of clinical visits fluctuated initially between increases and decreases, the number of surgical procedures decreased across the study period, and the use of several diagnostic techniques stayed below baseline, potentially influencing patient outcomes in the future. To assess the short- and long-term effects of the COVID-19 pandemic on health care delivery in the United States, new data sources in other specialties as well as the AQUA Registry are necessary.

Recent Development

• In April 2019 –Boston Scientific Corporation announces a four year exclusive marketing agreement with Bladder Health Network.

Global Urodynamic Testing Market Scope

The urodynamic testing market is segmented on the basis of test type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Uroflowmetry
• Electromyography
• Cystometric Test
• Leak Point Pressure Measurement Test
• Others

End User

• Hospitals
• Diagnostic Laboratories
• Others

Urodynamic Testing Market Regional Analysis/Insights

The urodynamic testing market is analysed and market size insights and trends are provided by country, test type, and end-user as referenced above.

The countries covered in the urodynamic testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

由于北美尿失禁患病率不断上升，北美占据了尿动力学测试市场的主导地位。

由于人们对泌尿疾病及其影响的认识不断提高，预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和尿动力学检测市场份额分析

尿动力学检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对尿动力学检测市场的关注有关。

尿动力学测试市场的一些主要参与者包括：

• 美国实验室控股公司（美国）
• Quest Diagnostics Incorporated（美国）
• Accu 参考医疗实验室（美国）
• Eurofins Scientific（卢森堡）
• 泌尿科专家（美国）
• 阿肯色州泌尿科（美国）
• 梅奥基金会（美国）
• 美敦力（爱尔兰）
• BD（美国）
• Albyn Medical SL（西班牙）
• 波士顿科学公司 (美国)
• Coopersurgical, Inc.（美国）
• LABORIE（美国）
• Verathon, Inc.（美国）
• Medica SpA（意大利）
• Neomedix Systems Pty. Ltd.（澳大利亚）
• DANTEC DYNAMICS LTD（丹麦）

SKU-57116